Similar Articles

Multimodal Evoked Potentialsin Follow-up of Treatment of Multiple Sclerosis With lnterferon Beta-1 a

Serkan ÖZAKBAŞ, Raif ÇAKMUR, Vesile ÖZTÜRK, Egemen İDİMAN, Fethi İDİMAN

Issue: 2001, Volume 7 - Issue 1
0 169

lnterferon Beta-1b In TheTreatment Of Relapsing Remitting Multiple Sclerosis:Clinical and Magnetic Resonance lmaging Results

Serkan ÖZAKBAŞ, Egemen İDİMAN, Handan ÇAKMAKÇI, İlhami KOVANLIKAYA

Issue: 2001, Volume 7 - Issue 1
0 205

Obstetrical Brachial Plexus Palsy: Outcome with Conservative Managementand Factors Effecting the Prognosis

Okter AMAÇ, Ferah GENEL, Füsun ATLIHAN, İbrahim ÖZTURA, Nedret URAN

Issue: 2001, Volume 7 - Issue 1
0 179

Paroxysmal Dyskinesia: Report of Four Cases

Funda UYSAL TAN, Hatice BALABAN, Sedat ULKATAN, Cenk AKBOSTANCI

Issue: 2001, Volume 7 - Issue 1
0 203

Cytokines in Multiple Sclerosis

A. ALTINTAŞ, O. KANTARCI, S. SAİP, A. SİVA, S. ÖZTUZCU, N. HEKİM, P. BOZKURT

Issue: 2000, Volume 6 - Issue 4
0 168

Beta lnterferon-lA Treatment in Multipl Sclerosis and Cognitive Functions

E. İDİMAN, G. G. YENER, G. AKDAL, S. ÖZAKBAŞ

Issue: 2000, Volume 6 - Issue 4
0 177

Temporal Arteritis

F. GÖKÇAY, A. GÖKÇAY, F. YILMAZ, G. YÜCE

Issue: 2000, Volume 6 - Issue 1
0 190

The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.

D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN

Issue: 1999, Volume 5 - Issue 1
0 155

Multiple Sclerosis and Fatigue

Nur YÜCEYAR, Ayşe SAĞDUYU

Issue: 1999, Volume 5 - Issue 1
0 149

Subacute Myleo-Optic Neuropathy- Case Report

Egemen VARDARLI, Gürbüz GÜMÜŞDİŞ, Sevgi TAVUS

Issue: 1998, Volume 4 - Issue 3-4
0 148

New Developments in Parkinson's Disease Management

M. Cenk AKBOSTANCI

Issue: 1998, Volume 4 - Issue 1-2
0 146

Clinical Scales for Multiple Sclerosis

Kadriye ARMUTLU, Rana KARABUDAK

Issue: 1997, Volume 3 - Issue 3-4
0 221

HLA Tissue Antigens in Multiple Sclerosis

Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL

Issue: 1996, Volume 2 - Issue 3-4
0 161

Serum Vitamin B12 and Folate Levels in Multiple Sclerosis

H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER

Issue: 1996, Volume 2 - Issue 3-4
0 211

Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.

Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM

Issue: 1996, Volume 2 - Issue 1-2
0 152

THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS

Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA

Issue: 1995, Volume 1 - Issue 4
0 157

Multiple Sclerosis Cases with Atypical Signs

Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY

Issue: 1995, Volume 1 - Issue 2
0 159

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy

DOI: 10.4274/tnd.2021.63444

Issue: 2021, Volume 27 - Supplement 1
0 274

The lmmunopathogenesis of Multiple Sclerosis

Nihal Işık

Issue: 2009, Volume 15 - Supplement 3
0 247

Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis

Rana KARABUDAK

Issue: 2009, Volume 15 - Supplement 3
0 278